Investment Performance Update
Source: http://feedproxy.google.com/~r/stockshaven/~3/Gpyq1QCcmGI/Posted on Tuesday, August 18th, 2009 | In Market Commentary, Stocks to Watch
At this time, StocksHaven Investments would like to recall and look back at the last few months of equity advice in order to showcase the proven track record. The following is a list of chosen companies which have been nothing short of stellar, giving investors much needed short term and long term gains despite the ongoing hostile recessionary environment.
1. Spongetech Delivery Systems, Inc. (+948% as of April/1/09) [ Article Link ]
2. Mesa Air Group, Inc. (+75% as of April/24/09) [ Article Link ]
3. Hemispherx Biopharma, Inc. (+ 52% as of May/8/09) [ Article Link ]
4. Access Pharmaceuticals (+57% as of June/10/09) [ Article Link ]
5. Nephros, Inc. (+58.4% as of June/17/09) [ Article Link ]
6. Bioelectronics Corp. (+1913% as of June/19/09) [ Article Link ]
7. TerreStar Corporation (+44% as of July/9/09) [ Article Link]
8. Hard to Treat Diseases, Inc. (+1045% as of July/21/09) [ Article Link ]
9. Somaxon Pharmaceuticals, Inc. (+67.26% as of July/22/09) [ Article Link ]
10. SymPowerco Corp. (+157.14% as of July/29/09) [ Article Link ]
Recent news on our latest pick, (PINK:SYMW)
Tom Bustamante, the Managing Partner of Ludlow Capital Research commented, “With the recent announcement of Chevy’s electric Volt the demand for alternative electric vehicles has been gaining strong interest. On the small cap side, SymPowerco’s subsidiaries, HOSS Motor Sports and Highline Hydrogen Hybrids Systems, should offer operating holding corps for joint ventures and development of electric motor car solutions.”
“The stock is considered highly speculative, but seems to be attracting increasing attention from the market. Technically the stock has been generating increasing strong retail volume, and looks to be making an attempt to move above their longer-term trend line moving average. Again, it may be a very small speculative micro-cap play, but on mere momentum we wouldn’t be surprised to see this company push up above the $0.01 mark in the very near-term.”
Technical Analysis
According to StockTA.com, short, medium, and long term indicators display the largest level of BUY RATING near the 100% level. Resistance is set to 0.0025 which should be tested within the coming days. Any new company PRs regarding the acquisition process of the new subsidiaries, and or an update on the facility in Dumas, Arkinsas, and you can expect the price per share to easily surpass the 0.0030 level.
—
By reading StocksHaven Investments you agree to the disclaimer, and thereby will not hold Michael Vlaicu accountable for any transactions or decisions you make. It is up to you to do your own due diligence.
Related Posts
Last 5 posts by Michael Vlaicu
- Technical Breakout Alert Issued for CytRx (NASDAQ:CYTR) - November 23rd, 2009
- Technical Trading Alert for Echo Therapeutics (OTC:ECTE.OB) - November 20th, 2009
- Power3 Investors Looking Forward to Upcoming Expo (OTC:PWRM.OB) - November 18th, 2009
- Bullish Technical Breakout Alert (OTC:SNBP.OB) - November 17th, 2009
- Bullish Technical Breakout Alert (OTC:SNGX.OB) - November 11th, 2009
BioElectronics Corp., electric motor car solutions, Hemispherx Biopharma Inc.;, Highline Hydrogen Hybrids Systems, HOSS Motor Sports, Ludlow Capital Research, managing partner, Market Commentary, Mesa Air Group Inc.;, Michael Vlaicu;, Nephros Inc., PRs, retail volume, Somaxon Pharmaceuticals Inc., SpongeTech Delivery Systems Inc, Stocks to Watch, StocksHaven Investments;, SymPowerco Corp., TerreStar Corporation, Tom Bustamante;, Treat Diseases Inc., USD
![]() About Michael Vlaicu (http://www.stockshaven.com)
A young and savvy, yet experienced and accomplished investments mogul since ‘01; Michael has amassed a fortune as a private self investor. Recently starting his own successful blog and turning it in to a self-proprietorship — StocksHaven Investments, a company offering advice to thousands of people worldwide and attracting contracts from various reputable sources. The financial news portal can be found at www.StocksHaven.com. Michael has reached Expert Stock Analyst status from a variety of accredited publications. |



